Author:
Liu Li,Dollery Stephen J.,Tobin Gregory J.,Lu Guoyu,Du Ke
Abstract
AbstractQuantitative analysis of human papillomavirus (HPV)-infected cervical cancer is essential for early diagnosis and timely treatment of cervical cancer. Here, we introduce a novel energy transfer-labeled oligonucleotide probe to enhance the loop-mediated isothermal amplification (LAMP) assay for highly sensitive and specific detection of HPV 16. Conducted as a single-step assay within a digital nanofluidic chip featuring numerous reaction reservoirs, our method facilitates target amplification under isothermal conditions. Targeting an HPV 16 gene, our chip demonstrates the capability to detect HPV DNA at concentrations as low as 1 fM, spanning a dynamic range of five orders of magnitude. Importantly, our digital chip allows for highly quantitative detection of target genes at low concentrations, with the correlation between target concentration and the number of microwells exhibiting fluorescence signals. Furthermore, we have developed a computer vision method for automated and 100% accurate quantification of target concentrations. This research holds promising applications in clinical diagnosis and is poised for seamless integration into both hospital and point-of-care settings.
Publisher
Cold Spring Harbor Laboratory
Reference22 articles.
1. Cervical cancer. https://www.who.int/health-topics/cervical-cancer (accessed 2024-01-28).
2. Human Papillomavirus (HPV). https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/human-papillomavirus (accessed 2024-01-23).
3. 2020 list of human papillomavirus assays suitable for primary cervical cancer screening
4. Impact of cervical screening by human papillomavirus genotype: Population-based estimations
5. Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects